The mathematics of drug dose individualization should be built with random-effects linear models

Francisco J. Diaz, Jose De Leon

Research output: Contribution to journalLetterpeer-review

14 Scopus citations
Original languageEnglish
Pages (from-to)276-277
Number of pages2
JournalTherapeutic Drug Monitoring
Issue number2
StatePublished - Apr 2013

Bibliographical note

Funding Information:
Supported by Frontiers: The Heartland Institute for Clinical and Translational Research CTSA UL1TR000001 (awarded to the University of Kansas Medical Center). The authors acknowledge Mrs Rosemary Morrow, at the Department of Biostatistics of the University of Kansas Medical Center, who helped in editing this letter.

ASJC Scopus subject areas

  • Medicine (all)

Cite this